Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 453

1.

Melanoma simulating atypical fibroxanthoma.

Sangüeza M, Zelger B.

Am J Dermatopathol. 2007 Dec;29(6):551-4.

PMID:
18032950
2.

Pigmented atypical fibroxanthoma: a tumor that may be easily mistaken for malignant melanoma.

Diaz-Cascajo C, Weyers W, Borghi S.

Am J Dermatopathol. 2003 Feb;25(1):1-5.

PMID:
12544091
3.

Malignant melanomas simulating various types of soft tissue tumors.

Zelger BG, Steiner H, Wambacher B, Zelger B.

Dermatol Surg. 1997 Nov;23(11):1047-54.

PMID:
9391563
4.

Clear cell atypical fibroxanthoma:a clinicopathologic study.

Crowson AN, Carlson-Sweet K, Macinnis C, Taylor JR, Battaglia T, LaMar WL, Minor D, Sutter S, Hill T.

J Cutan Pathol. 2002 Jul;29(6):374-81.

PMID:
12135470
5.

Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.

Gleason BC, Calder KB, Cibull TL, Thomas AB, Billings SD, Morgan MB, Hiatt KM, Smoller BR.

J Cutan Pathol. 2009 May;36(5):543-7. doi: 10.1111/j.1600-0560.2008.01099.x. Epub 2009 Mar 30.

PMID:
19476522
6.

Recurrent atypical fibroxanthoma of the cheek.

Skoulas IG, Price M, Andrew JE, Kountakis SE.

Am J Otolaryngol. 2001 Jan-Feb;22(1):73-5.

PMID:
11172219
7.

Pigmented atypical fibroxanthoma.

Diaz-Cascajo C, Borghi S, Bonczkowitz M.

Histopathology. 1998 Dec;33(6):537-41.

PMID:
9870148
8.

Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.

de Feraudy S, Mar N, McCalmont TH.

Am J Surg Pathol. 2008 Aug;32(8):1111-22. doi: 10.1097/PAS.0b013e31816b8fce.

PMID:
18545147
9.

CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.

Clarke LE, Frauenhoffer E, Fox E, Neves R, Bruggeman RD, Helm KF.

J Cutan Pathol. 2010 Jul;37(7):737-43. doi: 10.1111/j.1600-0560.2010.01532.x. Epub 2010 Feb 18.

PMID:
20175824
10.
11.

Localized cutaneous metastases from an atypical fibroxanthoma.

Giuffrida TJ, Kligora CJ, Goldstein GD.

Dermatol Surg. 2004 Dec;30(12 Pt 2):1561-4. Review.

PMID:
15606841
12.

Metastasizing atypical fibroxanthoma (cutaneous malignant histiocytoma): report of five cases.

Cooper JZ, Newman SR, Scott GA, Brown MD.

Dermatol Surg. 2005 Feb;31(2):221-5; discussion 225.

PMID:
15762219
13.

Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.

Kram A, Stańczyk J, Woyke S.

Pol J Pathol. 2003;54(4):267-71.

PMID:
14998296
14.

CD117 is not a useful marker for diagnosing atypical fibroxanthoma.

Beer TW, Haig D.

Am J Dermatopathol. 2009 Oct;31(7):649-52. doi: 10.1097/DAD.0b013e3181a766fa.

PMID:
19652583
15.

Collision tumour: atypical fibroxanthoma and invasive melanoma.

Wilsher MJ.

Pathology. 2009;41(7):699-701. doi: 10.3109/00313020903305746. No abstract available.

PMID:
20001356
16.

Atypical fibroxanthoma in a young female misdiagnosed clinically as a malignant melanoma--An unusual presentation.

Pujani M, Hassan MJ, Jetley S.

J Cancer Res Ther. 2015 Oct-Dec;11(4):1027. doi: 10.4103/0973-1482.150353.

17.

Immunohistochemical distinction of cutaneous spindle cell carcinoma.

Morgan MB, Purohit C, Anglin TR.

Am J Dermatopathol. 2008 Jun;30(3):228-32. doi: 10.1097/DAD.0b013e31816de820.

PMID:
18496422
18.
19.

CD117 immunoreactivity in atypical fibroxanthoma.

Mathew RA, Schlauder SM, Calder KB, Morgan MB.

Am J Dermatopathol. 2008 Feb;30(1):34-6. doi: 10.1097/DAD.0b013e31815b8ed5.

PMID:
18212542
20.

Immunohistochemical staining of CD10 in atypical fibroxanthomas.

Hultgren TL, DiMaio DJ.

J Cutan Pathol. 2007 May;34(5):415-9.

PMID:
17448198

Supplemental Content

Support Center